"Start-up activities underway for Phase 2 clinical trial in acute graft-versus-host disease (aGvHD) following Investigational New Drug (IND) clearance by the US Food and Drug Administration (FDA)
o On track to open initial study sites in the coming months"
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)